Finance

Lists
0874:HKG
Guangzhou Baiyunshan Pharmaceutical Holdings Company Ord Shs H
13,50 HKD
+1,50%
(+0,20) 1D
16-окт., 11:51:53 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0874...
Open
13,42 HKD
High
13,51 HKD
Low
13,40 HKD
Mkt. cap
36,51 млд
Avg. vol.
1,08 млн
Volume
476,00 миң
Dividend
6,39%
Quarterly dividend
0,22 HKD
Ex-dividend date
2026-ж., 10-сен.
P/E ratio
6,36
52-wk high
20,40 HKD
52-wk low
12,74 HKD
EPS
2,12 HKD
Shares outstanding
219,90 млн
No. of employees
26 миң
Open
13,42 HKD
High
13,51 HKD
Low
13,40 HKD
Mkt. cap
36,51 млд
Avg. vol.
1,08 млн
Volume
476,00 миң
Dividend
6,39%
Quarterly dividend
0,22 HKD
Ex-dividend date
2026-ж., 10-сен.
P/E ratio
6,36
52-wk high
20,40 HKD
52-wk low
12,74 HKD
EPS
2,12 HKD
Shares outstanding
219,90 млн
No. of employees
26 миң
News stories
From web sources and news partners
About Guangzhou Baiyunshan Pharmaceutical Holdings Company Ord Shs H
CEO-
Employees26,4 миң
Founded1997-ж., 1-сен.
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
19,77 млд
16,05 млд
23,28 млд
18,81 млд
Cost of goods sold
16,58 млд
14,37 млд
18,55 млд
16,29 млд
Cost of revenue
16,58 млд
14,37 млд
18,55 млд
16,29 млд
Research and development expenses
158,44 млн
217,91 млн
158,68 млн
184,69 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,88 млд
2,21 млд
2,22 млд
1,83 млд
Operating expense
2,05 млд
2,50 млд
2,55 млд
2,11 млд
Total operating expenses
18,63 млд
16,87 млд
21,10 млд
18,40 млд
Operating income
1,14 млд
-820,04 млн
2,18 млд
409,74 млн
Other non operating income
83,07 млн
-100,40 млн
-1,28 млн
-15,15 млн
EBT including unusual items
1,09 млд
-494,18 млн
2,21 млд
393,99 млн
EBT excluding unusual items
1,24 млд
-825,17 млн
2,21 млд
377,21 млн
Income tax expense
271,49 млн
-156,77 млн
383,93 млн
59,00 млн
Effective tax rate
24,82%
31,72%
17,39%
14,97%
Other operating expenses
-46,93 млн
164,17 млн
91,90 млн
62,67 млн
Net income
793,91 млн
-326,94 млн
1,78 млд
312,16 млн
Net profit margin
4,02%
-2,04%
7,66%
1,66%
Earnings per share
-
-
-
-
Interest and investment income
117,54 млн
187,01 млн
140,88 млн
97,52 млн
Interest expense
-101,91 млн
-95,60 млн
-103,44 млн
-110,76 млн
Net interest expenses
15,64 млн
91,41 млн
37,44 млн
-13,24 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,29 млд
-660,36 млн
2,34 млд
583,55 млн
Gain or loss from assets sale
3,63 млн
-107,74 млн
-
-938,61 миң
AI content may include mistakes. Learn more
Google колдонмолору